Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

5 Stocks With Prime Earnings Surprises — ABMD UBA WRI RDCM BRE

This week, these five stocks have the best ratings in Earnings Surprises, one of the eight Fundamental Categories on Portfolio Grader.

7 Restaurant and Resort Stocks to Buy Now

Seven restaurant and resort stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

NXP Semiconductors Continues to Deliver (NXPI)

NXPI is a major player in the secure mobile space and works with the world's largest companies to make mobile communications secure and reliable.

Zillow Stock Is a Buy Despite Lousy Response to Earnings

Zillow stock may not look like much from a valuation standpoint, but give it time -- it's a story stock, and the story is moving forward for the better.

4 Big Pharma Stocks to Own After Q2 Earnings

Big Pharma has a lot to be proud of following some key second-quarter filings and revised full-year outlooks. Four stocks in particular look buy-worthy.

3 Muscle-Bound Stocks That Will Pull the Bulls Ahead

We've sorted out 13 relative strength leaders that should carry the Nasdaq forward from here, but three in particular look like market-pulverizing ideas.

5 Stocks to Buy for August

Technical strength, strong seasonality and solid fundamentals are hallmarks of these five stocks to buy for outperformance, at least in the short term.

Disney Stock: A Rare Discount Thanks to Earnings (DIS)

Deep discounts in Disney stock don't come along all that often, so buyers should take advantage of this quick souring on DIS shares.

The Sun Is Shining Bright At First Solar (FSLR)

First Solar earnings are doing wonders for FSLR stock after its blowout Q2 report. It's a stock to buy despite today's ferocious rally.

Priceline (PCLN) Stock: Still a Buy After Blowout Earnings

Priceline (PCLN) stock continues to beat the market in 2015 as shares hit all-time highs in the wake of blowout Q2 earnings. It's still a buy.

7 Insurance Stocks to Buy Now

The grades of seven insurance stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

10 Best “Strong Buy” Stocks — HOLX AGN MMI and more

This week, these ten stocks, all currently earning A's ("strong buy") on Portfolio Grader, have the best year-to-date performance.

Rotten Apple? No Way – AAPL Stock Is Still an AMAZING Buy

Apple stock price charts hint that the pullback will continue for a bit, but patient investors should be ready to snap up AAPL stock on the dip.

EBay Stock: Business Is Still Strong Without PayPal

The PayPal spin-off left eBay stock whistling to itself in the corner, but the selloff just might have been overdone.

4 Commercial Services Stocks to Buy Now

The grades of four commercial services stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

6 Biotechnology Stocks to Buy Now

Six biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

5 Semiconductor Stocks to Buy Now

Five semiconductor stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

5 Stocks With Strong Earnings Momentum — KNSY FTEK QLYS EVAC CEB

This week, these five stocks have the best ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.

RAI: Reynolds American Goes Smokeless for U.S. Growth

The compelling growth story for RAI isn't just its winning brands. It's about over-the-counter nicotine replacement therapies.